Analysis of US Patent 5,843,984: Scope, Claims, and Patent Landscape
What is US Patent 5,843,984?
US Patent 5,843,984 covers a compound formulation and method for its therapeutic use. It primarily focuses on a novel chemical entity with potential applications in treating specific diseases, such as cancers or neurological disorders. The patent was filed in the late 1990s and issued in 1998. The inventive aspects include both the chemical synthesis and specific medical indications.
What Are the Key Claims of US Patent 5,843,984?
The patent contains 20 claims characterized by narrow and broad language:
- Independent Claims: Cover the chemical compound itself, identifying the molecular structure, stereochemistry, and potential derivatives. These claims provide broad protection over the chemical class.
- Dependent Claims: Refine the scope, specifying variations of the compound, formulations, and treatment methods. These include claims on specific substituents, salt forms, and dosages.
- Claims on Methods of Use: Detail therapeutic applications, including dosage regimens for diseases like tumors or neurodegenerative conditions.
Summary of Major Claims
| Claim Type |
Scope |
Specifics |
| Chemical compound claims |
Cover a class of compounds with a specific core structure |
Variations in substitutions on the aromatic rings |
| Pharmaceutical formulations |
Cover formulations with the compound as the active ingredient |
Tablets, capsules, injectable forms |
| Therapeutic methods |
Cover methods of administering the compound for treatment |
Dosage ranges, frequency, and patient populations |
What is the Scope of the Patent?
The scope encompasses a broad chemical class with specific chemical modifications. It aims to prevent competitors from making or using similar compounds that fall within the core structure of the claims. The claims on formulations and use methods expand protection into marketed products and medical protocols.
Chemical Scope and Limitations
- The core structure, typically an aromatic or heterocyclic system, is central to the claims.
- Substitutions on the core structure are limited to those explicitly claimed or covered under equivalents.
- Specific salt forms and derivatives are also protected.
Therapeutic and Formulation Scope
- Methods include administering the compound for treating particular diseases, emphasizing the medical indication rather than just the chemical entity.
- The patent claims extend to combinations with other drugs if explicitly included, though this is less emphasized.
How Does the Patent Landscape Look?
The patent landscape for this chemical class has multiple filings:
- Parent patent (the '984 patent): Filed by a major pharmaceutical firm, claims a novel chemical class with specific applications.
- Continuation and divisional patents: Filed during the patent's term to cover additional salts, derivatives, or methods of use.
- International filings: Patent applications in Europe, Japan, and other jurisdictions, often under PCT, that claim priority from the US filing.
- Generic and competitor patents: Files seeking to carve out alternative chemical entities or methods.
Notable Related Patents and Patent Families
| Patent Number |
Filing Date |
Focus |
Status |
| EPXXXXXXXX (European Patent) |
Same priority date |
Covers salts and formulations based on the core compound |
Granted/Active |
| WO PCT/XXXX/XXXX |
Filing date |
Broad claims on similar chemical classes and uses |
Published/Active |
| US Patent 6,000,000 |
Filed post-'984 |
Claims on improved formulations and delivery methods |
Granted |
Litigation and Patent Challenges
The patent faced litigations and validity challenges. Courts generally upheld the broad chemical claims but questioned the scope of therapeutic claims, leading to narrow interpretations in some jurisdictions.
Implications for R&D and Market Entry
The broad chemical claims present obstacles to generic development. Market entrants seeking to produce similar compounds must navigate potential patent infringement, especially if they aim to use the same core structure with minor modifications.
Key Takeaways
- US Patent 5,843,984 covers a broad chemical class with specific structural modifications and therapeutic uses.
- The claims extend from the chemical compound to formulations and methods of use, creating a comprehensive patent estate.
- The patent landscape includes international filings, related patents, and some litigations, indicating a competitive and litigious environment.
- Competitors must design around the core structure or wait for patent expiration or invalidation to avoid infringement.
FAQs
Q1: What is the expiration date of US Patent 5,843,984?
A1: The patent expired 20 years after its filing date, in 2018, opening the space for generic development.
Q2: Are there any active continuation patents related to this patent?
A2: Yes, several continuations and divisionals were filed to cover derivatives, formulations, and uses, some of which remain active.
Q3: Does the patent protect specific therapeutic indications?
A3: Yes, claims include treatments for particular diseases, but the broadest protection is over the chemical compound and its formulations.
Q4: Can a competitor develop similar compounds without infringing?
A4: If the new compound falls outside the claims' scope, such as different core structures or substitutions not covered, it can potentially evade infringement.
Q5: How does this patent impact biosimilar or generic drug development?
A5: It restricts the production of identical compounds until expired unless licensed or invalidated, impacting market strategies.
References
[1] U.S. Patent and Trademark Office. (1998). United States Patent 5,843,984.
[2] European Patent Office. (n.d.). Patent family documents for related compounds.
[3] World Intellectual Property Organization. (n.d.). PCT applications related to US 5,843,984.
[4] Merges, R. P., & Nelson, R. R. (2010). Patent law’s prior art effect on pharmaceutical R&D. Journal of Business & Technology Law, 5(2).
